4.6 Article Proceedings Paper

Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis

期刊

SURGERY
卷 152, 期 3, 页码 397-402

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.surg.2012.05.007

关键词

-

类别

向作者/读者索取更多资源

Background. Sarcomatoid lung carcinomas are unusual, and reports from small single institution case series suggest poor survival rates. We sought to study the clinical characteristics of this form of non small cell lung cancer using the Surveillance Epidemiology, End Results database. Methods. The Surveillance, Epidemiology, and End Results database was queried for respirator)) tract malignancies of sarcomatoid histology. The demographic information and oncologic characteristics of this population were examined. A propensity score matched analysis of patients was performed to test the hypothesis that patients with sarcomatoid cancers undergoing lobectomies perform worse that those with other non small cell lung cancers. Results. Of 878,810 patients with lung cancer, only 3,647 patients had a diagnosis of sarcomatoid cancer (0.4%). For the additional analyses of outcomes, only patients with lifetime incidence of a single cancer, known Surveillance, Epidemiology, and End Results historic stage and inpatient reporting were selected (n = 1,921). Demographics, tumor characteristics, and outcomes of these patients were described. Non small cell lung cancer cohorts (with and without sarcomatoid cancer propensity-matched on age, gender, race, year of diagnosis, grade, and Surveillance, Epidemiology, and End Results historic stage) that underwent lobectomies or pneumonectomies were selected (n = 758). Univariate (hazard ratio, 1.60; 95% confidence interval, 1.31-1.97) and multivariate analysis (hazard ratio, 1.67; 95% confidence interval, 1.36-2.05) revealed a significantly worse overall survival for patients with sarcomatoid cancer compared to matched nonsarcomatoid lung cancer controls. Conclusion.,Sarcomatoid cancer is a rare form of lung malignancy with outcomes significantly worse than other forms of non small cell lung cancer Novel multimodality treatment strategies are necessary to improve outcomes of this disease. (Surgery 2012;152:397-402.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据